A New Dawn in Fertility Treatment
In a landmark development, the world has witnessed the first successful human birth resulting from a novel fertility technology developed by Gameto. Read More
Since Louise Brown, the first ‘test tube baby,’ was born in 1978, IVF has become a beacon of hope for millions facing fertility challenges. However, despite its success, conventional IVF has its drawbacks, including long treatment cycles and significant physical and emotional strain. Enter Fertilo: a technique refined by the female-led biotech firm Gameto, which aims to revolutionize women’s reproductive health by addressing these challenges. Fertilo distinguishes itself by employing ovarian support cells (OSCs) derived from human induced pluripotent stem cells (iPSCs). These cells are co-cultured with immature eggs to mimic natural egg maturation in a lab setting. This innovative approach not only reduces the hormonal burden but also significantly shortens the treatment cycle to just three days. A 2023 study confirmed the efficacy of this method, noting marked improvements in egg maturation and embryo formation. Dr. Dina Radenkovic, CEO and co-founder of Gameto, elaborates on the advantages of Fertilo, highlighting its ability to mitigate the major pitfalls of conventional IVF such as the emotional and physical toll on patients, and the extensive use of hormone injections which can lead to conditions like ovarian hyperstimulation syndrome. By minimizing these aspects, Fertilo offers a safer, faster, and more accessible fertility treatment option. Following its initial success, Fertilo has gained regulatory clearance in several countries, including Australia, Japan, and various nations in Latin America, with plans underway for Phase 3 trials in the United States. This expansion is a testament to the technology’s potential and Gameto’s commitment to broadening access to innovative reproductive solutions. The significance of Fertilo extends beyond scientific achievement, touching lives on a very personal level. The mother of the first Fertilo baby shared her relief at choosing a method that reduced the number of injections and provided a gentler approach to egg retrieval. Her positive experience underscores the method’s potential to alleviate the burdens typically associated with fertility treatments. As Fertilo continues to make inroads across the globe, it not only offers a new hope for couples struggling with infertility but also stands as a pioneer of the next generation of reproductive technologies. With its blend of advanced science and patient-centered care, Fertilo could soon redefine the landscape of fertility treatments worldwide. This milestone not only marks a significant advancement in reproductive health technology but also ignites a new era of hope for countless individuals aspiring to parenthood under challenging conditions. Reference link: https://pmc.ncbi.nlm.nih.gov/articles/PMC1129084/ The Evolution of IVF and Introduction to Fertilo
The Science Behind Fertilo
Benefits of the New Method
Global Adoption and Future Prospects
Personal Stories of Hope
Conclusion